Trauma Triage and Trauma System Performance

le Johnson, Gary
Foilsithe in West J Emerg Med (2016)

Management of Sickle Cell Disease Super Utilizers

le Johnson, Gary A.
Foilsithe in West J Emerg Med (2017)

Noncanonical Function of MEKK2 and MEK5 PB1 Domains for Coordinated Extracellular Signal-Regulated Kinase 5 and c-Jun N-Terminal Kinase Signaling

le Nakamura, Kazuhiro, Johnson, Gary L.
Foilsithe 2007

The c-Jun Kinase/Stress-activated Pathway: Regulation, Function and Role in Human Disease

le Johnson, Gary L., Nakamura, Kazuhiro
Foilsithe 2007

Sequence patches on MAPK surfaces define protein-protein interactions

le Johnson, Gary L, Gomez, Shawn M
Foilsithe 2009

Implications of Mesenchymal Cells in Cancer Stem Cell Populations: Relevance to EMT

le Abell, Amy N., Johnson, Gary L.
Foilsithe in Curr Pathobiol Rep (2014)

MEK Inhibition in Non-Small Cell Lung Cancer

le Stinchcombe, Thomas E., Johnson, Gary L.
Foilsithe in Lung Cancer (2014)

Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-a...

le Knall, Cindy, Worthen, G. Scott, Johnson, Gary L.
Foilsithe 1997

Data-driven modeling of cellular stimulation, signaling and output response in RAW 264.7 cells

le Wu, Yang, Johnson, Gary L, Gomez, Shawn M
Foilsithe 2008

MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis

le Pham, Trang T., Angus, Steven P., Johnson, Gary L.
Foilsithe 2013

Assessing adaptation of the cancer kinome in response to targeted therapies

le Zawistowski, Jon S., Graves, Lee M., Johnson, Gary L.
Foilsithe in Biochem Soc Trans (2014)

Identification of Ponatinib and Other Known Kinase Inhibitors with Potent MEKK2 Inhibitory Activity

le Ahmad, Syed, Johnson, Gary L., Scott, John E.
Foilsithe in Biochem Biophys Res Commun (2015)

Landscaping a chromatin response to MEK inhibition

le Zawistowski, Jon S., Goulet, Daniel R., Johnson, Gary L.
Foilsithe in Cell Cycle (2017)

Pharmacologic targeting of drug-induced enhancers

le Zawistowski, Jon S., Bevill, Samantha M., Johnson, Gary L.
Foilsithe in Oncoscience (2017)

Enhancer remodeling regulates epigenetic adaptation and resistance to MEK1/2 inhibition in triple-negative breast cancer

le Bevill, Samantha M., Zawistowski, Jon S., Johnson, Gary L.
Foilsithe in Mol Cell Oncol (2017)

Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer

le Jordan, Nicole Vincent, Johnson, Gary L, Abell, Amy N
Foilsithe 2011

Epigenetic inhibition of adaptive bypass responses to lapatinib by targeting BET Bromodomains

le Stuhlmiller, Timothy J., Miller, Samantha M., Johnson, Gary L.
Foilsithe in Mol Cell Oncol (2015)

Identification of the glucagon receptor in rat liver membranes by photoaffinity crosslinking

le Johnson, Gary L., MacAndrew, Vincent I., Pilch, Paul F.
Foilsithe 1981

Phenotypic Characterization of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis

le Katz, Martin L., Johnson, Gary S., Tullis, Gregory E., Lei, Bo
Foilsithe 2007

Fluorochrome-Labeled Inhibitors of Caspases: Convenient In Vitro and In Vivo Markers of Apoptotic Cells for Cytometric Analysis

le Darzynkiewicz, Zbigniew, Pozarowski, Piotr, Lee, Brian W., Johnson, Gary L.
Foilsithe 2011